Table 2.
Patient and family history in relation to the etiology of MMR-D.
| History | No. of patients (%) |
P value | Pairwise P values | ||
|---|---|---|---|---|---|
| HM-MSI (n = 103) | LS-MSI (n = 28) | DS-MSI (n = 17) | |||
|
| |||||
| Met diagnostic criteria | |||||
| Revised Bethesda | 40 (39) | 26 (93) | 13 (77) | <0.001 | <0.0001,a 0.007,b 0.179c |
| Amsterdam III | 0 | 10 (36) | 0 | <0.001 | <0.0001,a 0.007c |
| Personal history | |||||
| Metachronous CRC | 4 (4) | 8 (29) | 0 | <0.001 | 0.0005,a 1.000,b 0.017c |
| Synchronous CRC | 3 (3) | 1 (4) | 0 | 0.752 | |
| LS-related neoplasmsd | 4 (4) | 3 (11) | 0 | 0.199 | |
| Family history | |||||
| CRC | 37 (36) | 22 (79) | 5 (29) | <0.001 | <0.0001,a 0.785,b 0.002c |
| LS-related neoplasmsd | 22 (21) | 14 (50) | 5 (29) | 0.012 | 0.004,a 0.532,b 0.222c |
Abbreviations: CRC, colorectal cancer; DS, double somatic; HM, hypermethylation; MMR-D, mismatch repair deficient; LS, Lynch syndrome; MSI-H, microsatellite instability-high.
HM-MSI vs LS-MSI
HM-MSI vs DS-MSI
LS-MSI vs DS-MSI
Noncolorectal